Midazolam Hydrochloride

CHEMBL1200420 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
362.2 g/mol
LogP
Phase
4

This is the hydrochloride salt form of midazolam used in injectable and intranasal formulations; see midazolam for full prescribing information.

Peso molecular

362,2000 g/mol

TPSA

30,20 Ų

Áreas terapéuticas

Mecanismo de acción

Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl

InChI

InChI=1S/C18H13ClFN3.ClH/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13;/h2-9H,10H2,1H3;1H

Molecular Formula

C18H14Cl2FN3

HBD / HBA

1 / 3

Enlaces Rotables

1

Átomos Pesados

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This is the hydrochloride salt form of midazolam used in injectable and intranasal formulations; see midazolam for full prescribing information.

Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Yes, Midazolam Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200420. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 43032. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.